|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 08847550.4 (espacenet) (Federated) (European Patent Register), 20081030 | Patent/reg. no. and date | DK/EP 2207787, 20141112 | Publication date | 20100721 | Priority no. and date | US 2049, 20071106 | EP pub. no. and date |
EP 2207787 20100721 | Effective date | | Applicant/owner | AdiuTide Pharmaceuticals GmbH, Alt Fechenheim 34
60386 Frankfurt am Main, DE | Applicant ref. no. | P81500276DK00E | Inventor | UHLMANN, Eugen, Zum Talblick 31
61479 Glashütten, DE, DEBELAK, Harald, Richard-Wagner-Str. 41
40724 Hilden, DE | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/7088 (2006.01) , A61P 37/04 (2006.01) , C07H 21/00 (2006.01) | Title | Immunstimulerende oligoribonukleotidanaloger indeholdende modificerede oligofosfatenheder | Int. application no. | IB2008002940 | Int. publication no. | WO2009060281 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |